Iodine Antimicrobial Solution pH Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current iodine solutions lack stability and effectiveness as antimicrobial agents, particularly in maintaining a stable pH and efficient delivery systems for various applications.
Innovation Solution
A liquid antimicrobial solution comprising at least 80% water or alcohol as a carrier, with specific concentrations of I2 and CuSO4, and sufficient acid to maintain a pH of less than 6.5, along with sulfamic acid for stability and buffering to maintain a pH range of 5.8-7.0, and encapsulation systems for controlled delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional iodine solutions are used, then antimicrobial activity is achieved, but stability and pH control are insufficient
Solution Approach 1:
The patent modifies the chemical parameters of iodine solutions by adding specific acids (sulfamic acid, hydrochloric acid, nitric acid) to control and stabilize pH within the range of 2.0-6.5. This parameter change resolves the contradiction by maintaining optimal acidity for antimicrobial activity while preventing pH drift that would reduce stability.
Solution Approach 2:
The invention creates a composite iodine solution system combining iodine (I2), potassium iodide (KI), and buffering agents (sulfamic acid, hydrochloric acid, nitric acid). This composite formulation achieves both antimicrobial effectiveness through iodine release and pH stability through the buffering system, resolving the contradiction between these two requirements.
2Reliability
If iodine concentration is increased to improve antimicrobial activity, then effectiveness increases, but solution stability decreases
Solution Approach 1:
The patent optimizes the concentration parameters by maintaining iodine at 0.0005-0.10% and potassium iodide at 0.001-0.10%, with pH controlled at 2.0-6.5. This parameter optimization allows sufficient antimicrobial activity while preventing excessive iodine concentration that would cause precipitation and reduce stability.
Solution Approach 2:
The patent introduces potassium iodide and buffering agents as intermediary substances that mediate between iodine concentration and solution stability. These intermediaries allow higher effective iodine concentrations while maintaining solution stability through complex formation and pH control.
3Ease of manufacture
If simple iodine solution formulation is used, then ease of manufacture is maintained, but performance and stability are insufficient
Solution Approach 1:
The patent develops a composite formulation containing iodine, potassium iodide, and specific buffering acids. While more complex than simple iodine solutions, this composite approach maintains relative manufacturing simplicity while dramatically improving antimicrobial performance and pH stability through the synergistic interaction of components.
4Reliability
If pH is lowered to improve antimicrobial activity, then effectiveness increases, but solution becomes more corrosive
Solution Approach 1:
The patent optimizes pH to be maintained between 2.0-6.5, which is acidic enough for antimicrobial effectiveness but controlled to minimize excessive corrosiveness. This parameter optimization balances effectiveness with safety by preventing pH from becoming too low.
Solution Approach 2:
The patent applies local quality control by using buffering agents that maintain pH stability in the bulk solution, allowing the solution to be sufficiently acidic for antimicrobial activity without becoming uniformly highly corrosive throughout the solution system.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution provides enhanced antimicrobial and anti-odor effects, improved stability, and effective delivery in various formats, including gels and microencapsulated systems, suitable for diverse applications such as nuclear fuel control and medical treatments.
Implementation Method 1
at least 0.0005% by weight of the solution of I2
Implementation Method 2
sufficient acid in the solution to provide a pH of less than 6.5
Implementation Method 3
sulfamic acid for stability and buffering to maintain a pH range of 5.8-7.0
Implementation Method 4
encapsulation systems for controlled delivery
Implementation Method 5
encapsulation systems for controlled delivery
Data Source
AI summary
Antimicrobial solutions and delivery systems for them use liquid antimicrobial solutions with: at least 80% of total weight of a carrier liquid comprising water, alcohol or a mixture of water and alcohol; at least 0.0001% by weight of the solution of I2; at least 0.0001% by weight of CuSO4; and sufficient acid in the solution top provide a pH of less than 7.0. A buffering system is also preferable in the solution, and the solution may be provided directly to wounds, burns or other skin damage as a liquid, as a spray or as a gel.